Cargando…

ODP096 Hypercalcemia Secondary to Vitamin D Supplementation with Normal 25-Hydroxyvitamin D Level in an Elderly Female - Case Report

CASE PRESENTATION: A 92-year-old female with a history of heart failure, dementia (alert and oriented to time, place and person at baseline), osteoporosis and hypothyroidism presented to the emergency department with altered mental status and constipation. She was oriented to time and person only. L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arora, Gunjan, Patel, Toral
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Bone & Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624676/ http://dx.doi.org/10.1210/jendso/bvac150.339

Ejemplares similares

ODP079 BCG-Osis, a Rare Cause of 1,25 Hydroxy Vitamin D Mediated Hypercalcemia
por: Azim, Sidra, et al.
Publicado: (2022)

ODP093 Hunt for Hypercalcemia
por: Wang, Ally W, et al.
Publicado: (2022)

SAT246 Ectopic (Penile) Calcification in 1, 25 Vitamin D Induced Hypercalcemia
por: Berquist, John, et al.
Publicado: (2023)

ODP068 A Case Report of Nivolumab Associated Hypercalcemia
por: Sherpa, Chheki, et al.
Publicado: (2022)

SAT240 Recurrent Hypercalcemia Due To 1,25 Dihydroxy Vitamin D Elevation Of Unclear Etiology
por: Javvaji, Abhiram, et al.
Publicado: (2023)

ODP095 HYPERCALCEMIA FROM SILICONE BUTTOCK INJECTION INDUCED GRANULOMA.
por: Chin, Edward, et al.
Publicado: (2022)

ODP129 Variation in 25(OH)D Levels, Measurement Methods and Prevalence of Vitamin D Deficiency: a Systematic Review and Meta-analysis
por: Premaor, Melissa, et al.
Publicado: (2022)

ODP109 PARATHYROID HORMONE AND 25 OH VITAMINA D IN PREGNANCY: DATA FROM AN ARGENTINEAN COHORT SUPPORTING SUPPLEMENTATION.
por: Torres, Marta Isabel, et al.
Publicado: (2022)

Characteristics of Serum Ratios of 1,25-Dihydroxyvitamin D to 25-Hydroxyvitamin D for Assessment of Bone Metabolism
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

ODP102 Indicators for the effects of calcimimetics on hypercalcemia in the elderly patients with primary hyperparathyroidism.
por: Yamamoto, Koichro, et al.
Publicado: (2022)

ODP094 Hypercalcemia caused by Mycobacterium Avium Complex, with Excellent Response to Intravenous Pamidronate.
por: Khthir, Rodhan
Publicado: (2022)

ODP128 Unusually High Serum Calcium in a Patient with Familial Hypocalciuric Hypercalcemia
por: Spiro, Andrew J, et al.
Publicado: (2022)

ODP123 Severe Hypercalcemia During Lactation In A Patient With Pre-Existing Hypoparathyroidism
por: Sumal, Amit, et al.
Publicado: (2022)

SAT-510 Hypercalcemia Secondary to Vitamin D Intoxication and Nephrocalcinosis in 2 Children
por: Diaz, Alejandro, et al.
Publicado: (2019)

LBODP020 Treatment Of Hypercalcemia Due To Prolonged, Excessive Vitamin D Intake
por: Abdelrahman, Houda, et al.
Publicado: (2022)

MON-374 Management of 1,25-dihydroxyvitamin D (1,25-OHD) Mediated Hypercalcemia of Unknown Etiology
por: Menon, Sruthi, et al.
Publicado: (2020)

ODP106 Mystery of the Calcium: A Case of Exclusive Cutaneous Sarcoidosis presenting with Symptomatic Hypercalcemia
por: Kulkarni, Abhigna, et al.
Publicado: (2022)

ODP084 Denosumab as a therapuetic modality in management of primary hyperparathyroidism induced severe hypercalcemia
por: Mangaraj, Swayamsidha, et al.
Publicado: (2022)

ODP627 Hypercalcemia in a Patient With Gastrointestinal Stromal Tumor (GIST): Evaluation and Treatment Strategies
por: Kalra, Kriti, et al.
Publicado: (2022)

SAT-514 The Decrease in Serum Parathyroid Hormone on Vitamin D Treatment Is Similar When Comparing Increases in Serum Free or Total 25 Hydroxyvitamin D in White and Black Women
por: Smith, Lynette, et al.
Publicado: (2019)

1-25OH(2)D Mediated Hypercalcemia Secondary to DISR From Immune Checkpoint Inhibitors
por: Disanti, Domenic, et al.
Publicado: (2021)

Lack of Association Between 25-Hydroxyvitamin D Level and Outcomes in Hospitalized Indian Patients With COVID-19
por: Jevalikar, Ganesh, et al.
Publicado: (2021)

LBSAT229 Extended-release Calcifediol Effectively Raised 25-hydroxyvitamin D In CKD Despite Obesity
por: Strugnell, Stephen A, et al.
Publicado: (2022)

ODP069 A Clinical audit on the diagnosis and management of Vitamin D Deficiency at Scarborough General Hospital, United Kingdom
por: Abraham, Santhosh, et al.
Publicado: (2022)

ODP594 Vitamin D Levels At Hospital Admission Predict Severity Of Covid-19: A Controlled Prospective Study
por: di Filippo, Luigi, et al.
Publicado: (2022)

A Comparison of Free and Total 25-hydroxyvitamin D Levels as Functional Indicators of Bone Health in Healthy Children
por: Heo, You Joung, et al.
Publicado: (2021)

ODP122 Recurrent Episodes of Hypercalcemia due to Disseminated Mycobacterium Avium Complex Infection-related Immune Reconstitution Inflammatory Syndrome
por: Downs, Ian, et al.
Publicado: (2022)

The Effect of Vitamin D Supplementation on Severe COVID-19 Outcomes in Patients With Vitamin D Insufficiency
por: Levitus, Corinne, et al.
Publicado: (2021)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

SAT257 Efficacy Of Oral Cinacalcet In Non-PTH Non-Malignant Hypercalcemia From Excess 1,25 Dihydroxyvitamin D
por: Mohan, Sneha, et al.
Publicado: (2023)

Oleanolic Acid Modulates 25-Hydroxyvitamin D(3) 1-alpha-hydroxylase in Osteoblasts and Human Mesenchymal Stem Cells
por: Yu, Wen-Xuan, et al.
Publicado: (2021)

SUN-LB086 Hypercalcemia in Metastatic Cholangiocarcinoma Due to Coexisting Elevated Parathyroid Hormone Related Protein (PTHrP) and 1,25-Dihydroxy Vitamin D (Calcitriol): A Case Report
por: Sharma, Rajeev
Publicado: (2019)

Vitamin D Supplements: Over-the-Counter Accessibility... It Is Safe?
por: Figueroa-Cruz, Alegyari, et al.
Publicado: (2021)

ODP081 Bisphosphonates: To Give or Not to Give, that is the Question – A case of prolonged hypercalcemia in a patient with severe rhabdomyolysis complicated by bilateral foot drop
por: Musurakis, Clio, et al.
Publicado: (2022)

SAT260 Asymptomatic Vitamin A Toxicity Causing Hypercalcemia
por: Seshan, Nandini, et al.
Publicado: (2023)

LBODP016 Lithocholic Acid Induced 25-hydroxyvitamin D-1alpha Hydroxylase (cyp27b1) Expression And Activities In Vitro And In Vivo
por: Lam, Chung Yan, et al.
Publicado: (2022)

THU399 Increasing Testing And Use Of Vitamin D Supplements Leads To Slow Progress In Restoring Vitamin D Adequacy: An Interim Analysis Of The "Vitamin D Deficiency In Western Greece" Real World Data Study
por: Paparodis, Rodis D, et al.
Publicado: (2023)

SAT261 Hypervitaminosis A With Hypercalcemia Without Overtly Excessive Vitamin A Intake
por: Chiou, Cho-Yen, et al.
Publicado: (2023)

PSAT173 Weekly Supplementation with Vitamin D3 reduces 1,25(OH)2 vitamin D3 Measured by Mass Spectrometry, and increases Fibroblast-like growth factor 23 (FGF23) in Individuals with and without Primary Hyperparathyroidism (PHPT)
por: Sidana, Shivani, et al.
Publicado: (2022)

SAT254 Elevated Vitamin D 1,25-Dioh Leading To The Diagnosis Of Diffuse Large B-cell Lymphoma With Excessive Vitamin D Intake Confounding The Clinical Picture
por: Barai, Rakhee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fkg8a3qrl9ree7hkn424sr9imt